Extracorporeal Shock Wave Therapy to Kegel's Exercise in Management of Female Stress Urinary (NCT07663968) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Extracorporeal Shock Wave Therapy to Kegel's Exercise in Management of Female Stress Urinary
84 participantsStarted 2026-07-01
Plain-language summary
Stress urinary incontinence (SUI) is a common pelvic floor disorder among women, especially those with a history of childbirth, aging, or pelvic surgery. Stress urinary incontinence is defined as the complaint of involuntary leakage on effort or exertion, or on sneezing or coughing.
The condition significantly affects quality of life, emotional well-being, and daily functioning.
Who can participate
Age range
25 Years – 60 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Married Females
* Diagnosed with stress urinary incontinence, confirmed by clinical evaluation.
* Ability and willingness to perform KE and attend follow-up visits.
* Accepting informed consent.
Exclusion Criteria:
* Mixed urinary incontinence.
* Active urinary tract infection (symptomatic or laboratory) confirmed).
* Known coagulopathy or ongoing anticoagulant therapy.
* Neurological disorders (e.g., multiple sclerosis, stroke, spinal cord injury) or use of medications affecting bladder control.
* Pregnancy or recent childbirth (within 6 months)
* History of pelvic malignancy affecting urinary continence.
* History of recent surgical intervention or indicated for surgery for urinary incontinence.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in frequency and severity of stress urinary incontinence episodes
Timeframe: Patients will be assessed at 4 weeks, 8 weeks, 12 weeks, and 3 months from the date of the intervention startup.